Abstract:Background: Contrast-enhanced MRI is the best imaging modality for liver tumor detection and differential diagnosis. However, it is long scan times required and has the contrast agent-associated risks. This study aims to develop and validate a deep convolutional neural network for initial diagnosis of liver tumors based on non-contrast MRI. Methods: In total, 50418 images in enhanced MRI from 1959 patients with liver tumor in three center were enrolled. T2-weighted imaging, diffusion-weighted imaging (DWI), and multiphasic T1-weighted imaging provided input for Inception-ResNet V2 through transfer learning to generate four models for three-way classification. The models was then validated on the independent internal and two external datasets consisting of 5172 and 2916,1338 images, respectively. The diagnostic performance of non-contrast models(T2, T2+DWI) for distinguishing malignancy from benign tumors at-patient level were further evaluated in three validation sets. Findings: Non-contrast models demonstrated similar performance for classifying liver tumors to benign, primary malignant and metastatic tumors, compared with two models based on multi-sequence or enhanced images. In the independent internal cohort, the areas under the receiver operating characteristic curves of T2+DWI model reached 0.91(95% CI,0.888–0.932), 0.873(95% CI,0.848-0.899), and 0.876 (95% CI, 0.840-0.911) for three categories, respectively. At patient-level, the sensitivities of malignant tumors gained from non-contrast models reached 98.1%, 85.7%, 87.5% respectively in three validation sets, while all specificities were almost greater than 70%. Interpretation: This study demonstrates that based on non-contrast MRI, deep learning algorithm can correctly classify liver tumors into benign, primary malignant and metastatic tumors at image-level, and distinguish malignancy from benign with high sensitivity at patient-level, potentially reducing the number of enhanced testing to avoid side effects and financial costs. Funding Statement: This work was supported by grants from National Natural Science Foundation of China (81827804 to X.C.). Declaration of Interests: None. Ethics Approval Statement: This study was approved by the independent institutional review boards of three hospitals and performed according to the Helsinki declaration. The requirement for written informed consent was exempted because of the retrospective nature of this study.

Predicting Tumor Mutational Burden from Liver Cancer Pathological Images Using Convolutional Neural Network.

Based on Tumor Mutation Burden to construct diagnosis and prognosis models and provides guidance for the treatment in the Hepatocellular Carcinoma patients

Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma

Tumor Mutation Burden Analysis in a 5,660 Cancer Patient Cohort Reveals Cancer Type-Specific Mechanisms for High Mutation Burden.

Prediction of Tumor Mutation Load in Colorectal Cancer Histopathological Images Based on Deep Learning

Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning

Predicting gastric cancer tumor mutational burden from histopathological images using multimodal deep learning

Deep learning-based approach to reveal tumor mutational burden status from whole slide images across multiple cancer types

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

[Multi-classification prediction model of lung cancer tumor mutation burden based on residual network]

Pan-cancer Computational Histopathology Reveals Tumor Mutational Burden Status Through Weakly-Supervised Deep Learning.

Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study

Tumor Detection for Whole Slide Image of Liver Based on Patch-Based Convolutional Neural Network

Classification and Mutation Prediction Based on Histopathology H&E Images in Liver Cancer Using Deep Learning.

Biological Informed Graph Neural Network for Tumor Mutation Burden Prediction and Immunotherapy-Related Pathway Analysis in Gastric Cancer

Deep learning supported discovery of biomarkers for clinical prognosis of liver cancer

Deep learning-based Spatial Feature Extraction for Prognostic Prediction of Hepatocellular Carcinoma from Pathological Images

Liver Tumor Image Enhancement and CDK1 Gene Mutation Prediction Method

Predicting Tumor Mutation Burden of TNBC Based on Nuclei Scores of Histopathological Images.

Tumor Mutation Burden–Related Histopathologic Features for Predicting Overall Survival in Gliomas Using Graph Deep Learning

AI inspired discovery of new biomarkers for clinical prognosis of liver cancer